Amyloidosis – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Amyloidosis – Drugs In Development, 2024 report and make more profitable business decisions.
Abnormal accumulation of amyloid protein in the tissues results in a group of diseases known as amyloidosis. It can affect the shape and functioning of the affected organ, eventually leading to organ failure. Predisposing factors are misfolding of abnormal protein called the light chain and its subsequent deposition in the body. It may also occur as a result of dialysis. Symptoms include fatigue, chest pain, swelling, and breathing problems. Amyloidosis can be managed by transplant and medications such as diuretics and chemotherapy drugs.
The Amyloidosis drugs in development market research report provide comprehensive information on the therapeutics under development for Amyloidosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Amyloidosis and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Amyloidosis | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 69 molecules, with 62 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Amyloidosis therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Amyloidosis pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Amyloidosis treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
3SBio IncAbbVie Inc
ADEL Inc
ADRx Inc
Affiliated Hospital of Xuzhou Medical University
Alexion Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc
Alzheon Inc
Amgen Inc
Amyl Therapeutics
Assertio Therapeutics Inc
Attralus Inc
Autotac Bio Inc
BELLUS Health Inc
BridgeBio Pharma Inc
Bristol-Myers Squibb Co
BSIM Therapeutics SA
Corino Therapeutics Inc
Covalent Bioscience Inc
Dren Bio Inc
Elsie Biotechnologies Inc
Eterna Therapeutics Inc
GSK plc
HaemaLogix Pty Ltd
Hangzhou Sumgen Biotech Co Ltd
Huazhong University of Science & Technology
Illimis Therapeutics Inc
IMMvention Therapeutix Inc
Ionis Pharmaceuticals Inc
IRCCS Policlinico San Matteo
Johnson & Johnson
Lotus Pharmaceutical Co Ltd
Mabpharm Ltd
Millennium Pharmaceuticals Inc
Mitsubishi Tanabe Pharma Corp
Nanjing University
Nexcella Inc
Novo Nordisk AS
Paradox Immunotherapeutics Inc
Proclara Biosciences Inc
Prothena Corp Plc
R-Pharm
Recordati SpA
Regeneron Pharmaceuticals Inc
ResQ Biotech
Sanofi
Shanghai YaKe Biotechnology Co Ltd
Sirnaomics Ltd
SOLA Biosciences LLC
Sorrento Therapeutics Inc
Swedish Orphan Biovitrum AB
The Scripps Research Institute
University of California Los Angeles
Yaotang (Shanghai) Biotechnology Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Amyloidosis reports